Reason for posting: The use of coronary stents has improved the results of percutaneous
coronary revascularization procedures. Along with newer antithrombotic therapy using …

The clinical consequences of stent thrombosis are frequently catastrophic. This article
reviews the factors previously implicated in the occurrence of stent thrombosis and analyzes …

The long-term outcome and compliance of dual-antiplatelet therapy after implantation of
drug-eluting stent in the “real world” setting in Japan has not been well investigated. The …

When a potentially serious albeit uncommon complication such as stent thrombosis is
detected, it is mandatory that everything possible be done to aggressively examine the …

Objectives: This study investigated the risk of stent thrombosis associated with the use of
paclitaxel-eluting stents (PES) compared to bare-metal stents (BMS). Background: Clinical …

Aims Stent thrombosis is a serious complication of percutaneous coronary intervention
(PCI). We examined the incidence of stent thrombosis and other outcomes in patients …

Drug-eluting coronary stents are being used with increasing frequency in patients
undergoing percutaneous coronary intervention. Although these stents have shown …

In 1986, when pioneers such as Jacques Puel and Ulrich Sigwart implanted the first
coronary Wallstents, no guidelines were available to determine the treatment after stenting …

The introduction in clinical practice of coronary stents has set a milestone in the history of
interventional cardiology. Developed to overcome the limitation of plain old balloon …

Purpose: To report the results of a prospective, nonrandomized, multicenter study of a
semiconductor-coated stent in coronary lesions at high risk for stent thrombosis. Methods: A …